ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

14.21USD
16 Apr 2014
Price Change (% chg)

$1.41 (+11.02%)
Prev Close
$12.80
Open
$13.49
Day's High
$14.77
Day's Low
$13.40
Volume
931,138
Avg. Vol
314,750
52-wk High
$20.24
52-wk Low
$11.78

IMGN.OQ

Chart for IMGN.OQ

About

ImmunoGen, Inc. (ImmunoGen) develops targeted, antibody-based therapeutics for the treatment of cancer. ImmunoGen designs linkers that enable antibody-based therapeutics for the treatment of cancer agents to remain stably attached to the antibodies while in the blood stream and be released in their fully active form after... (more)

Overall

Beta: 1.95
Market Cap (Mil.): $1,217.41
Shares Outstanding (Mil.): 85.67
Dividend: --
Yield (%): --

Financials

  IMGN.OQ Industry Sector
P/E (TTM): -- 25.12 32.65
EPS (TTM): -0.36 -- --
ROI: -15.28 -2.94 19.01
ROE: -23.03 -12.86 19.78
Search Stocks

Immunogen halts trial of lung cancer drug; shares drop

- Immunogen Inc said it would discontinue a mid-stage trial of its experimental small-cell lung cancer drug following the death of a patient, sending its shares down 17 percent.

05 Nov 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks